Bhageria Industries Limited (NSE: BHAGERIA | BSE: 530803)
Source: Bhageria Industries Limited Annual Report FY 2025-26 (Fiscal Year Ended March 31, 2026) 📊 Stock Screeners
Bhageria Industries Limited is an established Indian multi-divisional industrial manufacturing powerhouse operating across specialty chemicals, renewable solar power generation, and active pharmaceutical ingredients (APIs). Headquartered in Mumbai, the corporate model is underpinned by three operational tenets articulated in its corporate theme: “Capacity, Capability, Continuity.” Rather than relying on single breakthrough market inflections, the enterprise drives value through deep backward integration, continuous manufacturing discipline, process automation, and steady organic capacity build-outs.
- H-Acid (1-Amino-8-Naphthol-3,6-Disulfonic Acid): The company’s flagship high-volume dye intermediate used extensively in manufacturing reactive black, blue, and brown dyes for cotton and cellulosic fibers. Plant capacity at Tarapur was expanded from 400 MT/month to 500 MT/month during the year, a strategic enhancement projected to unlock an incremental ₹50.00 to ₹75.00 Crores in annualized gross sales.
- Vinyl Sulphone: Key intermediate applied in reactive dyeing across modern textile operations, operating at a mature base capacity of 3,600 MTPA with superior yield kinetics.
- Gamma Acid: Critical intermediate utilized in synthesis of specialized deep-shade reactive blacks and high-fastness red dyes.
- Plasticizers: A newly commissioned high-margin specialty chemicals line launched at the Tarapur manufacturing complex in December 2025, broadening the portfolio into advanced industrial polymer processing.
📋 Quick Facts / Company Snapshot: Bhageria Industries Limited (NSE: BHAGERIA | BSE: 530803)
| Attribute | Disclosed Detail |
|---|---|
| Official Company Name | Bhageria Industries Limited |
| Corporate Identity Number (CIN) | L40300MH1989PLC052574 |
| ISIN | INE354C01027 |
| Stock Exchange Listing | NSE: BHAGERIA | BSE: 530803 |
| Date of Incorporation / Founding Year | July 12, 1989 (as Bhageria Dye Chem Limited) |
| Founders / Key Founding Figures | Mr. Suresh Bhageria and Mr. Vinod Bhageria |
| Registered Office | Office No. 1002, 10th Floor, Topiwala Centre, Off S.V. Road, Near Goregaon Railway Station, Goregaon (West), Mumbai – 400062, Maharashtra, India |
| Corporate Headquarters / Office | 17th Floor, Office No. 1702, 9 Business Bay, Off New Link Road, Mindspace, Behind Evershine Mall, Malad (West), Mumbai – 400064, Maharashtra, India |
| Telephone & Investor Email | Tel: (022) 4043 6666 / (022) 4043 6621 | Email: info@bhageriagroup.com |
| Chairman | Mr. Suresh Bhageria (Executive Chairman & Whole-time Director) |
| Managing Director | Mr. Vinod Bhageria (Managing Director) |
| Key Managerial Personnel (KMP) | Mr. Vikas Bhageria (Jt. Managing Director), Mr. Rakesh Kachhadiya (Chief Financial Officer), Mrs. Deepa Toshniwal (Company Secretary & Compliance Officer) |
| Promoter & Holding Group | Bhageria Family & Promoter Entities (Holding 71.77% aggregate equity stake) |
| Industry / Sector Classification | Dyes & Dye Intermediates, Specialty Chemicals, Renewable Energy (Solar Power), and Pharmaceuticals |
| Total Workforce Strength | 457 permanent employees on the rolls as of March 31, 2026 (51 new employees inducted during FY 2025-26) |
| Manufacturing Plants & Solar Assets | 3 Chemical plants (1 at Vapi, Gujarat; 2 at MIDC Tarapur, Maharashtra), 1 Pharma plant (Vapi, Gujarat), and 10 Ground-Mounted & Rooftop Solar Power Installations across Maharashtra, Tamil Nadu, and Rajasthan |
| Credit Ratings & Rating Agency | CARE Ratings: Long-term Bank Facilities rated CARE A; Stable / CARE A1 (and CARE A; Stable / CARE A1 [RWN]); Short-term Bank Facilities rated CARE A Stable / CARE A1 (and CARE A1 [RWN]) |
| Statutory Auditors | M/s Sarda & Pareek LLP, Chartered Accountants (FRN: 109262W/W100673) |
| Secretarial Auditors | M/s GMJ & Associates, Company Secretaries (ICSI Unique Code: P2011MH023200) |
| Cost Auditors | M/s K V M & Co., Cost Accountants (Firm Registration No. 000458) |
| Registrar & Share Transfer Agent (RTA) | MUFG Intime India Private Limited (formerly Link Intime India Pvt. Ltd.), C-101, 247 Park, LBS Marg, Vikhroli (West), Mumbai – 400083 |
🏢 The Corporate Identity: Bhageria Industries Overview, Promoters & History
The Big Picture: Business Model & Core Value Proposition
Bhageria Industries Limited is an established Indian multi-divisional industrial manufacturing powerhouse operating across specialty chemicals, renewable solar power generation, and active pharmaceutical ingredients (APIs). Headquartered in Mumbai, the corporate model is underpinned by three operational tenets articulated in its corporate theme: “Capacity, Capability, Continuity.” Rather than relying on single breakthrough market inflections, the enterprise drives value through deep backward integration, continuous manufacturing discipline, process automation, and steady organic capacity build-outs.
The company’s core specialty chemicals franchise produces high-volume dye intermediates—predominantly H-Acid, Vinyl Sulphone, Gamma Acid, and newly introduced Plasticizers—serving global textile, leather, paints, coatings, construction, plastics, and paper industries. Bhageria protects its operating margins against volatile raw material cost shocks through captive backward integration, producing essential inputs such as Sulphuric Acid at its Tarapur chemical complex. In parallel, the renewable energy division acts as a predictable cash flow generator and sustainability anchor, operating a robust mix of captive and third-party utility-scale and rooftop solar plants contracted under long-term Power Purchase Agreements (PPAs).
- Vertically Integrated Manufacturing: In-house production of Sulphuric Acid and key chemical reagents insulates downstream dye intermediate processing from global aromatic feedstock disruptions.
- Green Power Integration: Captive solar plants supply clean power to industrial facilities, while surplus steam generated from the Tarapur Sulphuric Acid plant is supplied to third-party industrial consumers for optimum waste-heat recovery.
- Export Market Diversification: Strong distribution footprints across Southeast Asia, the Far East, Europe, and the Americas insulate revenue streams from regional economic downturns.
- Emerging API Foothold: Targeted strategic investments in high-value Active Pharmaceutical Ingredients, specifically focusing on Vitamins and Steroids.
The Founders, Promoters & Their Legacy
Bhageria Industries was founded in July 1989 by promoter-entrepreneurs Mr. Suresh Bhageria and Mr. Vinod Bhageria. Over more than three and a half decades, the promoters guided the company from a single-product dye intermediate unit with a modest output into a globally accredited specialty chemicals exporter and green energy producer. Executive Chairman Mr. Suresh Bhageria brings more than 38 years of executive leadership in strategic planning, project implementation, and commercial management within the chemical sector. Managing Director Mr. Vinod Bhageria commands over 37 years of operational expertise spanning chemical manufacturing, corporate taxation, statutory auditing, and treasury management.
The leadership group expanded its executive bandwidth with the induction of Jt. Managing Director Mr. Vikas Bhageria, who holds a Bachelor’s degree in Commerce and a Master’s in Computer Applications. Mr. Vikas Bhageria has led the operational ideation, procurement, and execution of the company’s utility-scale and rooftop solar energy ventures since 2015, driving the group’s decarbonisation footprint.
The Journey: Corporate History & Key Milestones
From its initial establishment at Vapi, Gujarat, Bhageria Industries has systematically compounded its asset footprint across four decades of capital deployment and technological upgrades:
- 1989: Incorporated as Bhageria Dye Chem Limited on July 12, 1989, by promoters Mr. Suresh Bhageria and Mr. Vinod Bhageria.
- 1990: Set up specialty chemicals manufacturing operations and entered the dye intermediates sector by establishing a Vinyl Sulphone plant with an initial capacity of 540 MTPA.
- 1995: Completed an Initial Public Offering (IPO) to fund capacity expansions and diversify into advanced organic intermediates.
- 2002: Scaled the Vinyl Sulphone manufacturing capacity more than six-fold from 540 MTPA to 3,600 MTPA.
- 2015: Formally changed corporate name from Bhageria Dye Chem Limited to Bhageria Industries Limited, acquired prime industrial land in Vapi for expansion, and forayed into renewable solar energy with a 2.80 MWp rooftop portfolio.
- 2016: Executed a 25-year Power Purchase Agreement (PPA) with the Solar Energy Corporation of India (SECI) for 30 MW solar capacity, and listed equity shares on the National Stock Exchange of India (NSE).
- 2017: Successfully commissioned the 30 MW utility-scale solar power project in Ahmednagar, Maharashtra, and split equity share face value from ₹10 to ₹5 per share.
- 2018: Executed the statutory corporate merger of Nipur Chemicals Limited and declared its highest-ever equity dividend of 110% of face value.
- 2019: Rewarded shareholders with a 1:1 stock bonus issue.
- 2020: Commissioned a massive Sulphuric Acid plant at MIDC Tarapur with an installed capacity of 300 TPD to achieve complete raw material self-sufficiency.
- 2021: Acquired Bhageria & Jajodia Pharmaceuticals Private Limited as a subsidiary, establishing a formal operational entry into high-impact Active Pharmaceutical Ingredients (APIs).
- 2025: Commenced commercial production of Plasticizers at Tarapur and initiated expansion of flagship H-Acid capacity from 400 to 500 MT/month.
- 2026: Subsidiary Rahuri Cleantech Private Limited successfully commissioned a 7 MW solar plant at Pimpalgaon Wagha in February 2026, followed by a second 7 MW solar plant at Bhatkudgaon in March 2026, and an additional 7 MW plant at Khanapur in May 2026 under the Maharashtra MSKVY 2.0 framework, bringing online 21 MW of a planned 32 MW build-out. Completed the voluntary liquidation of overseas subsidiary Bhageria Industries Holding Company WLL in Bahrain.
The Corporate Umbrella & Group Structure
The group operates through Bhageria Industries Limited as the listed parent entity, supported by five active operating subsidiaries as of March 31, 2026. The corporate umbrella is structured to maintain clear operational demarcation between chemical processing, pharmaceutical formulation/bulk drug synthesis, and special purpose vehicle (SPV) clean energy assets:
- Bhageria Industries Limited (Parent Entity): Houses the primary specialty chemical manufacturing units at Vapi and Tarapur, as well as captive and grid-tied solar assets across Maharashtra, Tamil Nadu, and Rajasthan.
- Bhageria & Jajodia Pharmaceuticals Private Limited (51% Subsidiary): Operates the dedicated pharmaceutical bulk drugs and API manufacturing facility situated in GIDC Vapi, Valsad District, Gujarat, focusing on high-value Steroid and Vitamin therapies.
- Rahuri Cleantech Private Limited (100% Wholly Owned Subsidiary): Special Purpose Vehicle executing utility-scale solar power generation under Maharashtra’s Mukhyamantri Saur Krushi Vahini Yojana (MSKVY 2.0) with an aggregate 32 MW (AC) / 44.80 MW (DC) capacity build-out.
- Salasar Renewables Private Limited (100% Wholly Owned Subsidiary): Renewable clean energy project development vehicle incorporated in October 2024.
- Hikaru Solar Power Private Limited (100% Wholly Owned Subsidiary): Clean power generation vehicle incorporated in November 2024.
- New Ahilyanagar Solar Private Limited (100% Wholly Owned Subsidiary): Clean power generation vehicle incorporated in November 2024.
- Bhageria Industries Holding Company WLL (Liquidated): Wholly owned overseas investment arm incorporated in the Kingdom of Bahrain, officially liquidated with effect from November 20, 2025, to streamline international holdings.
⚙️ The Business Engine: Bhageria Industries Segments, Brands, Products & Operations
The Core Divisions & Segment Revenue Breakdown
Bhageria Industries categorises its operational activities into four primary reportable business segments under Ind AS 108: Chemicals, Solar Power, Pharmaceuticals, and Others (encompassing trading operations and solar Engineering, Procurement, and Construction [EPC] contract execution). During FY 2025-26, the Chemicals segment served as the primary growth engine, expanding its consolidated turnover by 64.49% YoY to ₹829.56 Crores, driven by near-maximum capacity utilisation and a strong rebound in export off-take.
| Segment Vertical | Consolidated Revenue (₹ Cr) | % Share of Gross Segment Revenue | Segment Results / EBIT (₹ Cr) | Segment Assets (₹ Cr) | Segment Liabilities (₹ Cr) |
|---|---|---|---|---|---|
| Chemicals | 829.56 | 94.92% | 69.26 | 533.66 | 91.79 |
| Solar Power | 27.13 | 3.10% | 11.39 | 248.70 | 116.55 |
| Pharma | 6.45 | 0.74% | (7.54) | 16.68 | 16.38 |
| Others (Trading & Solar EPC) | 10.82 | 1.24% | 1.25 | 17.45 | 11.57 |
| Total Segment Performance | 873.96 | 100.00% | 74.36 | 816.49 | 236.29 |
| Less: Finance Costs | — | — | 3.42 | — | — |
| Add / Less: Unallocated Corporate Items | — | — | (8.97) | 44.00 | 30.61 |
| Consolidated PBT / Net Total | 873.96 | 100.00% | 61.97 | 860.49 | 266.90 |
The Product & Service Catalog (with Operational KPIs, Order Book & Customer Concentration)
The company manufactures and distributes an extensive portfolio of specialized organic chemical intermediates, mineral acids, renewable energy generation assets, and developing bulk drug lines:
- H-Acid (1-Amino-8-Naphthol-3,6-Disulfonic Acid): The company’s flagship high-volume dye intermediate used extensively in manufacturing reactive black, blue, and brown dyes for cotton and cellulosic fibers. Plant capacity at Tarapur was expanded from 400 MT/month to 500 MT/month during the year, a strategic enhancement projected to unlock an incremental ₹50.00 to ₹75.00 Crores in annualized gross sales.
- Vinyl Sulphone: Key intermediate applied in reactive dyeing across modern textile operations, operating at a mature base capacity of 3,600 MTPA with superior yield kinetics.
- Gamma Acid: Critical intermediate utilized in synthesis of specialized deep-shade reactive blacks and high-fastness red dyes.
- Plasticizers: A newly commissioned high-margin specialty chemicals line launched at the Tarapur manufacturing complex in December 2025, broadening the portfolio into advanced industrial polymer processing.
- Sulphuric Acid & Oleum: Captive mineral acid production from the 300 TPD Tarapur unit, supplying vital reagents for internal sulfonation reactions while selling surplus output and high-pressure steam commercially.
- Solar Power Generation & Solar EPC Services: Grid-connected utility power generation under long-term PPAs alongside captive rooftop and ground-mounted solar plants across major industrial customers.
- Pharmaceutical APIs: Active development pipeline focused on niche, high-entry-barrier Active Pharmaceutical Ingredients, particularly therapeutic Steroids and Vitamins.
Operational utilization across primary chemical manufacturing plants held at peak levels of 95% to 97% throughout FY 2025-26. Under Ind AS 108 customer concentration guidelines, the company operates across a diversified global clientele spanning more than 10 export nations, ensuring that revenue stability is not tethered to any single patron. Raw material sourcing utilizes a disciplined combination of domestic basic chemicals (caustic soda, chlorine, benzene derivatives) and imported aromatic feedstocks (naphthalene), with total foreign exchange outflows for raw materials and trading goods standing at ₹92.94 Crores.
The Names You Know: Key Brands & Flagship Portfolio
While dye intermediates are largely procured by industrial B2B conglomerates under strict technical specifications, Bhageria markets its primary manufactured lines under recognized corporate product categories:
| Brand / Product Name | Category / Business Segment | Target Market & Key Positioning |
|---|---|---|
| Bhageria H-Acid | Specialty Chemicals (Dye Intermediates) | Global reactive dye producers; premium purity standard for deep black textile colorants |
| Bhageria Vinyl Sulphone | Specialty Chemicals (Dye Intermediates) | Textile processing and cellulosic fabric dye synthesis; high bonding efficiency |
| Bhageria Gamma Acid | Specialty Chemicals (Dye Intermediates) | High-fastness leather, paper, and textile coloration formulations |
| Tarapur Plasticizers Range | Industrial Specialty Chemicals | Polymer compounding, construction materials, automotive flexible plastics, and coatings |
| Rahuri Cleantech Solar | Renewable Energy Assets | State power distribution utilities (MSKVY 2.0) and corporate commercial open-access consumers |
Mapping the Domestic & Global Reach (India vs. Exports)
Bhageria Industries demonstrated extraordinary export velocity during FY 2025-26. Driven by structural chemical production discipline and environmental compliance curbs in China, international buyers shifted large-volume purchase contracts to compliant Indian manufacturers. As a result, the company’s export sales more than tripled, surging by 226.43% from ₹93.04 Crores in FY 2024-25 to ₹303.72 Crores in FY 2025-26.
| Geographic Market | FY 2025-26 Revenue (₹ Cr) | % Share of Consolidated Revenue | FY 2024-25 Revenue (₹ Cr) | Latest YoY (%) |
|---|---|---|---|---|
| India (Domestic Market) | 570.25 | 65.25% | 501.57 | +13.69% |
| International (Exports) | 303.72 | 34.75% | 93.04 | +226.44% |
| Total Consolidated Revenue | 873.96 | 100.00% | 594.61 | +46.98% |
The company’s export basket is widely distributed across leading global consumption hubs. Key export destinations and their respective shares of international chemical sales during the year include:
- China: Accounts for 74% of international shipments, driven by significant demand for high-grade dye intermediates from Chinese colorant synthesisers.
- Indonesia: Accounts for 6% of export volume, serving Southeast Asia’s booming textile printing mills.
- Turkey: Represents 5% of export turnover, catering to textile and leather processors straddling the European corridor.
- Thailand: Comprises 4% of foreign shipments for regional synthetic dyeing.
- South Korea: Constitutes 3% of international deliveries for performance dyes and electronic inks.
- Brazil: Captures 3% of export volumes across Latin American textile and apparel clusters.
- Bahrain: Represents 2% of international distribution.
- Other Global Markets (Japan, Mexico, Taiwan, etc.): Each contribute approximately 1% of export shipments, establishing deep multi-continental distribution redundancy.
The Brick & Mortar Footprint: Manufacturing Plants, R&D & Offices
Bhageria’s industrial infrastructure spans four advanced chemical and bulk pharmaceutical manufacturing units alongside an expanding portfolio of utility-scale and captive solar generation assets:
- Chemical Manufacturing Unit I (Vapi, Gujarat): Located at Plot No. 6310, Phase IV, GIDC Industrial Estate, Vapi – 396195, Gujarat. Houses foundational dye intermediate synthesis plants.
- Chemical Manufacturing Unit II (Tarapur, Maharashtra): Located at Plot No. D-17, MIDC Tarapur Industrial Area, Boisar, Palghar – 401506, Maharashtra. Features the expanded H-Acid unit and new Plasticizer processing blocks.
- Chemical Manufacturing Unit III (Tarapur, Maharashtra): Located at Plot No. E-137, MIDC Tarapur Industrial Area, Boisar, Palghar – 401506, Maharashtra. Operates the 300 TPD Sulphuric Acid plant and downstream Oleum synthesis loops.
- Pharmaceutical API Facility (Vapi, Gujarat): Situated at Plot No. 6102/10, Phase IV, GIDC Industrial Estate, Vapi, Valsad District – 396195, Gujarat. Operated under subsidiary Bhageria & Jajodia Pharmaceuticals Pvt. Ltd.
- Utility Solar Power Generation Assets:
- 30 MW Ground-Mounted Solar Power Plant at Ahmednagar, Maharashtra (contracted under long-term PPA with SECI).
- 11 MW (AC) / 15.40 MW (DC) Solar Plant at Pimpri Kolandar (Village Arangaon Dumala, Taluka Shrigonda, District Ahilyanagar, Maharashtra).
- 7 MWp Solar Power Plant at Pimpalgaon Wagha, Taluka Nagar, District Ahilyanagar, Maharashtra (commissioned February 2026).
- 7 MWp Solar Power Plant at Bhatkudgaon, Taluka Shevgaon, District Ahilyanagar, Maharashtra (commissioned March 2026).
- 7 MW Solar PV Plant at Khanapur, Maharashtra (commissioned May 2026).
- Captive & Rooftop Industrial Solar Installations:
- 1.20 MWp Rooftop Solar Installation at Lucas TVS Limited, Padi, Chennai, Tamil Nadu.
- 1.00 MWp Rooftop Solar Installation at Asahi India Glass Limited, SIPCOT Industrial Park, Irungattukottai, Sriperumbudur, Tamil Nadu.
- 480 KWp Rooftop Solar Installation at TRIL Infopark Limited, Ramanujan IT City, Taramani, Chennai, Tamil Nadu.
- 1,001.7 KWp Rooftop Solar Installation at Kajaria Ceramics Limited, Gailpur, Bhiwandi-Alwar Road, Alwar, Rajasthan.
- 1.10 MWp Ground-Mounted Solar Plant at Andur, Taluka Tuljapur, District Osmanabad, Maharashtra (captive Tarapur power supply).
- 4.00 MWp Ground-Mounted Solar Plant at Village Kombhalne, Talkole, District Ahmednagar, Maharashtra (captive Tarapur power supply).
- 2.25 MW (DC) Ground-Mounted Solar Plant under development at Tapi, Songadh, Gujarat, dedicated to self-captive consumption for the Vapi manufacturing plants.
📊 The Financial Health: Bhageria Industries Financial Statements & Numbers Simplified
Multi-Year Financial Highlights (₹ in Crores)
Across the five-year trajectory spanning FY 2021-22 through FY 2025-26, Bhageria Industries demonstrated resilience and structural cyclical recovery. Following global post-pandemic supply chain adjustments during FY 2022-23 and FY 2023-24, the enterprise registered three consecutive years of aggressive top-line acceleration, with FY 2025-26 achieving record total revenue and EBITDA.
| Financial Metric (₹ Cr) | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | Latest YoY (%) |
|---|---|---|---|---|---|---|
| Total Income (Standalone) | 880.56 | 604.07 | 511.82 | 505.10 | 605.28 | +45.77% |
| Revenue from Operations (Gross Standalone) | 873.96 | 594.61 | 494.97 | 501.49 | 596.22 | +46.98% |
| EBITDA (Standalone) | 102.25 | 90.82 | 60.54 | 58.14 | 125.00 | +12.59% |
| Profit After Tax (Standalone PAT) | 44.49 | 38.69 | 19.62 | 15.05 | 70.50 | +14.99% |
| Standalone Net Worth (Total Equity) | 600.34 | 557.14 | 519.48 | 504.41 | 506.74 | +7.75% |
| Basic Earnings Per Share (₹) | 11.52 | 9.68 | 4.50 | 3.45 | 16.15 | +19.01% |
| Dividend Payout (%) | 50.00% | 30.00% | 20.00% | 20.00% | 80.00% | – |
| Dividend Per Share (₹) | 2.50 | 1.50 | 1.00 | 1.00 | 4.00 | +66.67% |
Earnings, Expenses, & Take-Home Profits (Consolidated Profit & Loss)
The consolidated performance under Ind AS Schedule III reflects solid operating momentum, with revenue from operations expanding by 46.98% YoY to ₹873.96 Crores, supported by healthy volume gains across domestic and export markets.
| Statement of Profit and Loss (₹ in Crores) | FY 2025-26 | FY 2024-25 | Latest YoY (%) |
|---|---|---|---|
| Revenue from Operations | 873.96 | 594.61 | +46.98% |
| Other Income | 6.82 | 6.98 | -2.29% |
| Total Income | 880.79 | 601.59 | +46.41% |
| Expenses | |||
| Cost of materials consumed | 540.58 | 306.57 | +76.33% |
| Purchase of Stock-in-Trade | 93.41 | 35.91 | +160.12% |
| Changes in inventories of finished goods, work-in-progress and Stock-in-Trade | 3.91 | 9.29 | -57.91% |
| Employee Benefits Expenses | 27.97 | 23.83 | +17.37% |
| Finance Costs | 3.42 | 2.79 | +22.58% |
| Depreciation and Amortization Expenses | 32.62 | 31.42 | +3.82% |
| Other Expenses | 116.92 | 137.59 | -15.02% |
| Total Expenses | 818.82 | 547.41 | +49.58% |
| Profit before tax | 61.97 | 54.18 | +14.38% |
| Tax Expense | |||
| Current Tax | 22.41 | 20.26 | +10.61% |
| Deferred Tax Charged / (Credited) | (4.93) | (5.15) | -4.27% |
| Tax for earlier years | 0.00 | 0.38 | -100.00% |
| Total Tax Expense | 17.48 | 15.49 | +12.85% |
| Profit for the Year | 44.49 | 38.69 | +14.99% |
| Attributable to: Owners of the Company | 46.08 | 40.40 | +14.06% |
| Attributable to: Non-Controlling Interest | (1.59) | (1.71) | -7.02% |
| Other Comprehensive Income (OCI) | |||
| Re-measurement gains / (losses) on defined benefit obligations (net of tax) | 0.28 | (0.11) | N/M |
| Exchange differences on translation of foreign operations | (0.84) | (0.12) | +600.00% |
| Other Comprehensive Income for the year, net of tax | (0.56) | (0.24) | +133.33% |
| Total Comprehensive Income for the year | 43.94 | 38.46 | +14.25% |
| Basic and Diluted Earnings Per Equity Share (₹) (Face Value ₹5) | 10.56 | 9.26 | +14.04% |
Assets, Borrowings, & Net Worth (Consolidated Balance Sheet)
The consolidated balance sheet shows strong asset compounding, with the total asset base expanding by 17.43% YoY to ₹860.49 Crores. The expansion was propelled by heavy capital expenditure in the solar power vertical through subsidiary Rahuri Cleantech, causing Capital Work-In-Progress to climb from ₹10.80 Crores to ₹116.95 Crores.
| Consolidated Balance Sheet (₹ in Crores) | As at March 31, 2026 | As at March 31, 2025 | Latest YoY (%) |
|---|---|---|---|
| ASSETS | |||
| 1. Non-Current Assets | |||
| (a) Property, Plant and Equipment | 382.90 | 348.50 | +9.87% |
| (b) Capital Work-In-Progress | 116.95 | 10.80 | +982.87% |
| (c) Investment Property | 1.04 | 1.03 | +0.97% |
| (d) Intangible Assets | 0.01 | 0.01 | 0.00% |
| (e) Financial Assets: Investments | 1.83 | 1.41 | +29.79% |
| (f) Financial Assets: Other Financial Assets | 41.34 | 23.28 | +77.58% |
| (g) Other Non-Current Assets | 4.18 | 1.04 | +301.92% |
| Total Non-Current Assets | 548.26 | 386.07 | +42.01% |
| 2. Current Assets | |||
| (a) Inventories | 55.91 | 49.07 | +13.94% |
| (b) Financial Assets: Investments | 22.54 | 21.34 | +5.62% |
| (c) Financial Assets: Trade Receivables | 159.02 | 186.77 | -14.86% |
| (d) Financial Assets: Cash and Cash Equivalents | 5.05 | 2.41 | +109.54% |
| (e) Financial Assets: Bank Balances other than above | 1.53 | 28.79 | -94.69% |
| (f) Financial Assets: Loans | 1.04 | 0.54 | +92.59% |
| (g) Financial Assets: Other Financial Assets | 48.82 | 42.19 | +15.71% |
| (h) Current Tax Assets (net) | 0.76 | 4.78 | -84.10% |
| (i) Other Current Assets | 17.55 | 10.81 | +62.35% |
| Total Current Assets | 312.23 | 346.70 | -9.94% |
| TOTAL ASSETS | 860.49 | 732.76 | +17.43% |
| EQUITY AND LIABILITIES | |||
| Equity | |||
| (a) Equity Share Capital | 21.82 | 21.82 | 0.00% |
| (b) Other Equity | 575.40 | 536.42 | +7.27% |
| (c) Non-Controlling Interests | (3.63) | (2.04) | +77.94% |
| Total Equity | 593.59 | 556.20 | +6.72% |
| 1. Non-Current Liabilities | |||
| (a) Financial Liabilities: Borrowings | 75.84 | 2.97 | +2453.54% |
| (b) Financial Liabilities: Lease Liabilities | 8.29 | 1.32 | +528.03% |
| (c) Financial Liabilities: Other Financial Liabilities | 0.04 | 0.02 | +100.00% |
| (d) Provisions | 3.63 | 3.61 | +0.55% |
| (e) Deferred Tax Liabilities (Net) | 21.13 | 25.97 | -18.64% |
| (f) Other Non-Current Liabilities | 15.31 | 13.54 | +13.07% |
| Total Non-Current Liabilities | 124.24 | 47.43 | +161.94% |
| 2. Current Liabilities | |||
| (a) Financial Liabilities: Borrowings | 25.10 | 42.01 | -40.25% |
| (b) Financial Liabilities: Lease Liabilities | 0.00 | 0.00 | N/M |
| (c) Financial Liabilities: Trade Payables – MSME | 3.68 | 5.29 | -30.43% |
| (d) Financial Liabilities: Trade Payables – Other than MSME | 70.80 | 62.99 | +12.40% |
| (e) Financial Liabilities: Other Financial Liabilities | 32.57 | 2.76 | +1080.07% |
| (f) Other Current Liabilities | 5.30 | 11.69 | -54.66% |
| (g) Provisions | 1.29 | 1.09 | +18.35% |
| (h) Current Tax Liabilities (Net) | 3.93 | 3.30 | +19.09% |
| Total Current Liabilities | 142.66 | 129.13 | +10.48% |
| Total Liabilities | 266.90 | 176.56 | +51.17% |
| TOTAL EQUITY AND LIABILITIES | 860.49 | 732.76 | +17.43% |
Working Capital Cycle & Schedule III Statutory Ratio Explanations
Working capital management improved significantly during FY 2025-26 as accelerated product turnover in dye intermediates unlocked cash flow from inventory and trade receivables. Inventory turnover improved from 9.16 times in FY 2024-25 to 13.73 times in FY 2025-26, while debtor velocity accelerated from 3.47 times to 5.05 times.
| Statutory Ratio | FY 2025-26 | FY 2024-25 | YoY Variance (%) | Management Statutory Explanation |
|---|---|---|---|---|
| Current Ratio (times) | 2.19 | 2.68 | -18.48% | Normal operational variance within comfortable liquidity limits. |
| Debt-Equity Ratio (times) | 0.22 | 0.11 | 105.23% | Increase driven by disbursement of Axis Bank term loan in subsidiary Rahuri Cleantech for executing the 32 MW MSKVY solar project. |
| Debt Service Coverage Ratio (times) | 23.57 | 26.11 | -9.73% | Remains robust; reflects high cash earnings relative to interest obligations. |
| Return on Equity Ratio (%) | 10.18% | 9.68% | 5.15% | Expansion in annual net profit attributable to equity owners. |
| Inventory Turnover Ratio (times) | 13.73 | 9.16 | 49.85% | Higher operating velocity, faster inventory cycles, and chemical plant utilisation holding at 95-97%. |
| Trade Receivables Turnover Ratio (times) | 5.05 | 3.47 | 45.82% | Disciplined collections, enhanced credit control, and higher proportion of secured export shipments. |
| Trade Payables Turnover Ratio (times) | 9.01 | 5.56 | 62.18% | Expanded manufacturing raw material procurement volumes paid within credit cycle terms. |
| Net Capital Turnover Ratio (times) | 5.15 | 2.73 | 88.58% | Higher top-line operational turnover relative to net working capital employed. |
| Net Profit Margin (%) | 44.49 | 6.51% | -21.76% | Changes in product mix, aromatic feedstock pricing fluctuations, and increased logistics expenses. |
| Return on Capital Employed (%) | 12.82% | 12.78% | 0.30% | Stable returns across operational assets despite ongoing CWIP gestation in solar projects. |
| Return on Investment (%) | 8.21% | 8.09% | 1.44% | Steady asset productivity across manufacturing and power installations. |
Cash Flow: Tracking the Money Movement
Net cash flow from operating activities doubled during FY 2025-26, reaching ₹98.51 Crores compared to ₹49.49 Crores in FY 2024-25. The robust operating cash generation provided vital internal funding for the company’s capital investments in green energy and specialty chemical expansions.
| Consolidated Statement of Cash Flows (₹ in Crores) | FY 2025-26 | FY 2024-25 | Latest YoY (%) |
|---|---|---|---|
| Net Profit Before Tax | 44.49 | 54.18 | -17.88% |
| Operating cash flows before working capital changes | 95.04 | 84.44 | +12.55% |
| Cash generated from operations | 116.28 | 66.56 | +74.70% |
| Income taxes paid (net of refund) | (17.77) | (17.08) | +4.04% |
| Net Cash flow from Operating Activities (A) | 98.51 | 49.49 | +99.05% |
| Purchase or Construction of Property, Plant & Equipment (CapEx & CWIP) | 143.26 | 24.45 | +485.93% |
| Proceeds from / (Investment in) Fixed Deposits (net) | 0.23 | (25.40) | N/M |
| Proceeds from / (Investment in) Current Investments (net) | (2.84) | 0.76 | N/M |
| Interest Received | 4.42 | 4.24 | +4.25% |
| Dividend Received & Sale of Fixed Assets | 0.33 | 1.37 | -75.91% |
| Net Cash flow from / (used in) Investing Activities (B) | (141.12) | (43.48) | +224.56% |
| Dividends Paid on Equity Shares | (6.55) | (4.36) | +50.23% |
| Increase / (Decrease) in Non-Current & Current Borrowings | 55.67 | (2.48) | N/M |
| Finance Costs Paid | (2.46) | (2.24) | +9.82% |
| Lease Payments & Other Expenses | (0.57) | (0.12) | +375.00% |
| Net Cash flow from / (used in) Financing Activities (C) | 46.09 | (9.20) | N/M |
| Exchange Difference arising on conversion (D) | (0.84) | (0.12) | +600.00% |
| Net Increase / (Decrease) in Cash & Cash Equivalents (A+B+C+D) | 2.65 | (3.32) | N/M |
| Cash and Cash Equivalents at Beginning of Year | 2.41 | 5.73 | -57.94% |
| Cash and Cash Equivalents at End of Year | 5.05 | 2.41 | +109.54% |
Funding the Future: CapEx, CWIP, R&D Intensity & Net Foreign Exchange
The company expanded its capital investments during the fiscal year, with gross capital expenditure (including CWIP additions and capital advances) totaling ₹143.26 Crores. CWIP stood at ₹116.95 Crores as of March 31, 2026, comprising ₹102.79 Crores of projects under execution for less than 1 year, ₹8.95 Crores between 1-2 years, and ₹5.21 Crores between 2-3 years, with no suspended or overdue projects. Major outlays funded the 32 MW solar farm execution in Rahuri Cleantech and the 2.25 MW DC captive solar plant in Songadh, Tapi, Gujarat.
In accordance with statutory Section 134(3)(m) disclosures, Bhageria Industries maintained a substantial net foreign exchange surplus, driven by exports across Europe and Asia:
- Total Foreign Exchange Earned (Inflows): ₹303.72 Crores (up from ₹91.10 Crores in FY 2024-25).
- Total Foreign Exchange Used (Outflows): ₹92.94 Crores (compared to ₹92.96 Crores in FY 2024-25).
- Net Foreign Exchange Contribution: ₹210.78 Crores in net positive foreign currency balance.
- R&D Initiatives: While direct standalone R&D expenses were accounted within operational lab expenditures (₹0.41 Crores), continuous process refinement was deployed across the Vapi API division to stabilize bulk steroidal and vitamin syntheses.
👥 Power & Control: Bhageria Industries Governance, Leadership & Shareholding Pattern
The Brain Trust: Board of Directors & Key Managerial Personnel (KMP)
The governance structure of Bhageria Industries Limited features seven Directors, comprising three Executive Directors and four Non-Executive Independent Directors, including one Woman Independent Director. Independent directors maintain active oversight through dedicated audit and governance committees.
| Name of Director / KMP | Designation / Role | DIN | Category |
|---|---|---|---|
| Mr. Suresh Bhageria | Executive Chairman & Whole-time Director | 00540285 | Promoter & Executive |
| Mr. Vinod Bhageria | Managing Director | 00540308 | Promoter & Executive |
| Mr. Vikas Bhageria | Jt. Managing Director | 02976966 | Executive Director |
| Mr. Mukund Manohar Chitale | Independent Director | 00101004 | Non-Executive Independent |
| Prof. (Dr.) Ganapati Dadasaheb Yadav | Independent Director | 02235661 | Non-Executive Independent |
| Ms. Ameya Prakash Jadhav | Independent Director | 08696918 | Non-Executive Independent (Woman Director) |
| Mr. Vikas Goel | Independent Director | 08265897 | Non-Executive Independent |
| Mr. Rakesh L. Kachhadiya | Chief Financial Officer | — | Key Managerial Personnel (CFO) |
| Mrs. Deepa Toshniwal | Company Secretary & Compliance Officer | — | Key Managerial Personnel (CS – ICSI A66073) |
Who Owns the Stock? Shareholding Pattern
The promoter and promoter group maintains substantial equity ownership, holding 71.77% of the total issued equity share capital as of March 31, 2026. Exactly 100% of promoter equity holdings are maintained in dematerialised form.
| Shareholder Category | Number of Shares Held | % of Total Issued Capital |
|---|---|---|
| Promoter and Promoter Group | 3,13,22,615 | 71.77% |
| Resident Individuals | 63,32,900 | 14.51% |
| Bodies Corporate | 43,19,362 | 9.89% |
| Non-Resident Individuals (NRIs) | 5,49,185 | 1.26% |
| Hindu Undivided Families (HUFs) | 5,18,375 | 1.19% |
| Investor Education and Protection Fund (IEPF) | 3,82,911 | 0.88% |
| Foreign Portfolio Investors (FPIs) | 1,92,308 | 0.44% |
| Clearing Members & Relatives | 26,524 | 0.06% |
| Total Issued & Paid-Up Equity Capital | 4,36,44,180 | 100.00% |
- Bhageria Trade Invest Private Limited: 66,17,850 equity shares (15.16% equity stake).
- Akashdeep International Private Limited: 52,96,372 equity shares (12.14% equity stake).
- Mr. Suresh Keshavdeo Bhageria (Promoter): 40,65,334 equity shares (9.31% equity stake).
- Mr. Deepak Vishwambharlal Bhageria: 23,97,274 equity shares (5.49% equity stake).
- Mr. Rakesh Niranjanlal Bhageria: 21,42,436 equity shares (4.91% equity stake).
- Mr. Vikas Suresh Bhageria: 16,31,456 equity shares (3.74% equity stake).
🗺️ The Corporate Family Tree: Group Structure, Ratings & Contingent Liabilities
Subsidiaries, Associates, & Joint Ventures (Form AOC-1)
In terms of Section 129(3) of the Companies Act, 2013, the financial position and performance of Bhageria’s operating subsidiaries are summarized below:
| Entity Name | Relationship | Country | Equity Holding (%) | Turnover (₹ Cr) | Profit / (Loss) After Tax (₹ Cr) |
|---|---|---|---|---|---|
| Bhageria & Jajodia Pharmaceuticals Private Limited | Subsidiary | India | 51.00% | 2.34 | (3.24) |
| Rahuri Cleantech Private Limited | Wholly Owned Subsidiary | India | 100.00% | 0.28 | (0.25) |
| Salasar Renewables Private Limited | Wholly Owned Subsidiary | India | 100.00% | 0.00 | (0.01) |
| Hikaru Solar Power Private Limited | Wholly Owned Subsidiary | India | 100.00% | 0.00 | (0.01) |
| New Ahilyanagar Solar Private Limited | Wholly Owned Subsidiary | India | 100.00% | 0.00 | (0.01) |
| Bhageria Industries Holding Company WLL | Subsidiary (Liquidated Nov 20, 2025) | Bahrain | 0.00% | 0.06 | (0.01) |
Strategic Investments, Credit Ratings, Banking Consortium & Contingent Liabilities
The company maintains a strong balance sheet supported by conservative leverage and banking lines across leading private sector financial institutions:
- Banking Consortium Partners: Working capital and term loan facilities are extended by Axis Bank, Yes Bank, and Kotak Mahindra Bank. Primary security comprises hypothecation over current assets, backed by mortgage extensions on Vapi industrial property and corporate office premises.
- Independent Credit Ratings: CARE Ratings assigned ratings of CARE A; Stable / CARE A1 (and CARE A; Stable / CARE A1 [RWN]) for long-term facilities, and CARE A Stable / CARE A1 (and CARE A1 [RWN]) for short-term working capital facilities.
- Contingent Liabilities (Ind AS 37 Disclosures):
- Disputed Goods & Services Tax (GST) matters pending before Appellate Authorities: ₹6.60 Crores.
- Disputed Customs Duty claims pending before Additional Commissioner of Customs: ₹0.33 Crores.
- Disputed Gujarat Value Added Tax (VAT) claims pending before Tribunal: ₹0.09 Crores.
- Outstanding Bank Guarantees furnished by lenders on behalf of the group: ₹5.11 Crores.
- Total Quantified Contingent Liabilities: ₹12.13 Crores (vs ₹8.17 Crores in FY 2024-25).
- Capital Commitments: Estimated value of contracts remaining to be executed on capital account (net of capital advances) stood at ₹20.41 Crores as of March 31, 2026.
🎯 The Strategic Outlook: Competitive Moats, Risks, Growth Plans & FAQs
Competitive Advantages & Economic Moats
Bhageria Industries has established several key operational advantages across its core chemical operations:
- Integrated Sulfonation Architecture: Operating an in-house 300 TPD Sulphuric Acid unit creates a low-cost production structure for H-Acid and Vinyl Sulphone while generating surplus steam for industrial monetization.
- Stringent Effluent Infrastructure: Advanced zero-liquid discharge, multiple-effect evaporators, and deep integration with CETP complexes shield the company from regional environmental clampdowns that often disrupt non-compliant operators.
- Dual Energy Balancing: Renewable solar generation supplies captive green power across production facilities, offsetting grid energy tariffs while creating stable external revenue through long-term PPAs.
- Global Distribution Footprint: Direct customer relationships across more than 10 export nations provide volume stability and multi-regional demand diversification.
What Could Go Wrong? Key Challenges & Business Risks
While the business model is resilient, management actively monitors key operational risks:
- Feedstock Price Volatility: Basic aromatic building blocks (naphthalene, benzene) fluctuate with global petrochemical cycles, requiring dynamic pricing adjustments.
- Export Freight & Trade Friction: Shipping disruptions along major trade corridors and container rate variations can impact export delivery schedules and landed margins.
- Regulatory & Environmental Compliance: Operating in chemical synthesis requires continuous compliance with strict environmental norms, effluent guidelines, and evolving workplace safety standards.
- API Commercialisation Timeline: Active Pharmaceutical Ingredients involve multi-year qualification cycles, customer validation, and regulatory filings before achieving scale.
The Next Chapter: Growth, Order Pipeline & CapEx Initiatives
The company’s growth strategy centers on three disciplined capital allocation priorities:
- H-Acid Ramp-Up & Plasticizers Expansion: Full commercialisation of the expanded 500 MT/month H-Acid line is projected to generate ₹50.00 to ₹75.00 Crores in incremental annual sales, while the new Plasticizers portfolio broadens market reach.
- Solar Capacity Expansion: Completing the remaining capacity under the 32 MW MSKVY 2.0 framework through Rahuri Cleantech, alongside commissioning the 2.25 MW captive solar plant at Songadh, Gujarat.
- Pharmaceutical API Pipeline: Continued investments in research, development, and cleanroom infrastructure at the Vapi bulk drug unit to advance niche Steroid and Vitamin therapies.
The Verdict: Strategic Outlook & Conclusion
Bhageria Industries Limited closed FY 2025-26 with strong operational execution. Total income grew 46.41% YoY to ₹880.79 Crores, with export shipments surging past ₹300 Crores. The company’s combination of backward-integrated chemical production, expanding solar energy assets, and a clean balance sheet positions it well for continued compounding across its core markets.
Frequently Asked Questions (FAQs) About Bhageria Industries
Q1: What does Bhageria Industries Limited manufacture and what are its core products?
Bhageria Industries Limited manufactures specialty chemicals and dye intermediates—principally H-Acid, Vinyl Sulphone, Gamma Acid, and Plasticizers—alongside Sulphuric Acid and Oleum. The company also operates utility-scale and rooftop solar power plants and develops Active Pharmaceutical Ingredients (APIs) in Vitamins and Steroids.
Q2: What were Bhageria Industries’ revenue and profit in FY 2025-26?
On a consolidated Ind AS basis, Bhageria Industries recorded Total Income of ₹880.79 Crores, Revenue from Operations of ₹873.96 Crores, Operating EBITDA of ₹98.00 Crores, and Profit After Tax (PAT) of ₹44.49 Crores (with Net Profit attributable to owners of the company at ₹46.08 Crores).
Q3: Who are the primary promoters and executive leaders of the company?
The company was founded in 1989 by Mr. Suresh Bhageria (currently Executive Chairman & Whole-time Director) and Mr. Vinod Bhageria (Managing Director). Clean energy projects and solar execution are led by Jt. Managing Director Mr. Vikas Bhageria.
Q4: Where are the company’s manufacturing facilities located and what is its export share?
The company operates three chemical manufacturing facilities across Vapi (Gujarat) and MIDC Tarapur (Maharashtra), along with an API bulk drugs unit in Vapi. In FY 2025-26, export revenues stood at ₹303.72 Crores, accounting for 34.75% of total consolidated turnover across key markets including China, Indonesia, Turkey, Thailand, and South Korea.
Q5: What is Bhageria Industries’ credit rating, debt profile, and net worth?
As of March 31, 2026, the company reported consolidated Net Worth (Total Equity) of ₹593.59 Crores. Total consolidated borrowings stood at ₹100.94 Crores (comprising ₹75.84 Crores non-current borrowings and ₹25.10 Crores current borrowings), with cash and cash equivalents of ₹5.05 Crores. Bank facilities are rated CARE A; Stable / CARE A1 by CARE Ratings.
Note: Financial ratios, margins, YoY growth percentages, and % revenue shares are calculated by IndianCompanies.in based on disclosed Ind AS financial statements.
Official Site: https://www.bhageriagroup.com